EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Ryan Specialty Holdings, Inc.
RYAN

RYAN Ryan Specialty Holdings, Inc.

Ryan Specialty Holdings, Inc. · NYSE
Market Closed
38.12
▼ ⁦-1.41%⁩ (-0.55)
Market Cap$4.9B
Beta0.57
52w Low52w High
29.2859.19
Last Week
⁦-9.97%⁩
Last Month
⁦-14.28%⁩
Last 3 Months
⁦+15.13%⁩
Last Year
⁦-32.71%⁩
EL7 Factor Analysis
How we score this
Overall31
Weak — below market medianFalling StarF 5/8Better than 31% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
40
39.7x▼17.8xAround median
▸
Growth
79
14.4%▲7.1%Top tier
▸
Quality
54
——Around median
▸
Safety
13
——Bottom tier
▸
Capital Return
20
0.63%▼2.12%Bottom tier
▸
Momentum
33
-21.6%▼2.9%Bottom tier
▸
Sentiment
82
12▲3Top tier
Fair Value
Current price$38
Analyst target · 8 analysts
$48
⁦+26%⁩
See it clearly undervalued
Range ⁦$31–$69⁩
vs
DCF (estimate)
$39
⁦+3%⁩
Sees it fairly priced
⁦7.9⁩% discount · ⁦1⁩% growth
Bottom lineThe two methods disagree — estimate range ⁦$39–$48⁩.

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 8 analysts setting price target
$48.33
⁦+26.8%⁩
Current Price $38.12·Median $48.00
Low
$31.00
High
$69.00
Current price
$38.12
Average target
$48.33
Street summary

A slight rise in consensus with wide dispersion among analysts

The consensus price target rose from 47.44 to 48.33 over the last 30 days, an increase of 0.89 or 1.88%. The consensus remained unchanged over the last day or seven days, while the number of analysts increased from 7 to 8; therefore, the improvement appears limited and partly related to the addition of a new analyst, rather than a clear wave of broad-based estimate upgrades. The current range is between 31 and 69, with a median of 48, reflecting a notable divergence of opinions.

As of 2026-09-08
Revisions momentum · 30d
⁦+1.9%⁩
Average rating
★ 3.56
Buy
Analyst coverage
⁦18 (+1)⁩
New coverage
Buy conviction
44%
Mixed
Rating activity · 30d
0↑ · 0↓
Target dispersion
100%
Wide
Analyst ratings over time18 analysts rating
4
4
9
1
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.74 → 3.56
Recent analyst moves
  • = Reiterate2026-08-19
    Morgan Stanley
    Overweight
  • = Reiterate2026-08-03
    Cantor Fitzgerald
    Neutral
  • = Reiterate2026-08-03
    UBS
    Buy
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    39.71x
    3.16x25.26x
    Expensive
  • Forward P/E
    17.33x
    2.76x22.06x
    Expensive
  • EV / EBITDA
    —
    —
  • FCF Yield
    —
    —
  • Revenue Growth YoY
    14.4%
    -36.3%104.2%
    Near median
  • EPS Growth YoY
    113.3%
    -99.4%194.2%
    Strong
  • Gross Margin
    —
    —
  • ROIC
    —
    —
  • Net Debt / EBITDA
    —
    —
  • Dividend Yield
    0.6%
    0.6%9.0%
    Low
  • Payout Ratio
    67.6%
    9.8%97.8%
    Moderate
  • Altman Z-Score
    —
    —
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2026-07-30 data

Company Overview

Ryan Specialty Holdings operates in specialty insurance services through two interconnected platforms: wholesale brokerage and delegated underwriting authority, which includes binding authority and underwriting management. The company offers more than 300 specialty insurance products, manages 40 managing general underwriting units, and has more than 25 insurance companies, each supporting ten or more of these units; revenues are therefore tied to the distribution and underwriting of specialty risks and program management on behalf of retail brokers and insurance carrier partners. It is also expanding its scope through Ryan Re for reinsurance underwriting management, alternative capital solutions, benefits, self-insurance management, and structured solutions.

In Q2 fiscal 2026, revenue according to EDGAR was approximately $916.6 million, compared with management’s rounded reported revenue of $917 million, representing year-over-year growth of 7.2% driven by organic growth of 6.7% and a modest contribution from acquisitions. Net income was $42.3 million, while adjusted EBITDAC rose 6% to $327 million, and its margin declined from 36.1% to 35.7%, or 40 basis points. Adjusted earnings per share rose 12.1% to $0.74, while the first half of fiscal 2026 recorded organic growth of 8.9% and adjusted EBITDAC growth of 9.8%.

The performance mix was varied across the platform: underwriting management delivered strong results in transactional liability, transportation, international specialties, casualty, and reinsurance, while binding authority grew despite intensifying competition. Wholesale brokerage benefited from strength in casualty, construction projects, and data centers, while the property book declined modestly under pressure from falling rates and abundant capacity. For fiscal 2026 through Q2, trailing-twelve-month revenue reached $3.2 billion, compared with $3.1 billion in fiscal 2025.

What's Driving the Stock

  • Management raised its fiscal 2026 organic growth outlook to the high end of the mid-single-digit range, following organic growth of 6.7% in Q2 fiscal 2026 and 8.9% during the first half, but the outlook assumes a slowdown in the second half because of difficult comparisons and property pressures.
Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

  • Ryan Re is targeting the placement of $2 billion in reinsurance premiums during fiscal 2026, while RSUM launched its own Lloyd's consortium stamp to assume a 15% line on its pooled business beginning August 1, 2026; management says these structures expand available capital and accelerate product launches.
  • Construction projects and data centers supported Q2 fiscal 2026 results, particularly a group of large bound accounts in June 2026, and management describes the pipeline as strong; however, the timing of large project closings is irregular and cannot be predicted precisely.
  • Artificial intelligence investments have begun producing tangible operating metrics: during the twelve months ended Q2 fiscal 2026, each RSUM property employee completed 11% more quotes, and the company is now auditing five times as many files as it audited in the previous year.
  • The company repurchased 8.1 million shares for $260 million in Q2 fiscal 2026, then increased the repurchase program authorization by an additional $300 million and repurchased $42 million of shares during July 2026; this represents a use of capital alongside investment in talent and selective acquisitions.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +Ryan Specialty combines wholesale brokerage and delegated underwriting authority within a platform that offers more than 300 products and handles $32 billion in premiums, giving it broad visibility into emerging risks and the ability to develop products and provide capital for them quickly.
    • +Q2 fiscal 2026 results demonstrated the platform’s ability to grow despite declining property rates; revenue increased 7.2%, adjusted EBITDAC grew 6%, and adjusted earnings per share rose 12.1%.
    • +Newer businesses provide additional sources of diversification, as Ryan Re is targeting the placement of $2 billion in reinsurance premiums in fiscal 2026, while management said reinsurance, alternative capital, and benefits have begun making a tangible contribution to growth, margins, and earnings per share.
    • +The repurchase of 8.1 million shares for $260 million in Q2 fiscal 2026, together with a $300 million increase in authorization, supports the case for efficient capital allocation, while net credit leverage remained at 3.3 times, within management’s comfort range of 3 to 4 times.

    ▼ Selling Case6 pts

    • −The property business faces direct pressure from lower rates, abundant capacity, and intense competition within the E&S market and from the admitted market; rates on some large and exposed catastrophe accounts have fallen by between 25% and 35%, and management expects a moderate decline in the property book during fiscal 2026.
    • −The outlook at the high end of the mid-single-digit organic growth range for fiscal 2026, following growth of 8.9% in the first half, points to a clear slowdown in the second half; management attributed this to a difficult Q3 comparison, normalization of construction project growth, and intensifying competition in casualty.
    • −Management expects the adjusted EBITDAC margin for fiscal 2026 to decline by between 50 and 100 basis points year over year, after it already fell 40 basis points to 35.7% in Q2; pressures include absorbing talent investments, lower fiduciary investment income, and higher healthcare and benefits costs.
    • −The builders’ risk business remains under pressure from macroeconomic factors, while management expects weaker growth in binding authority because some business is shifting to the admitted market and facilities are emerging that compete aggressively for small commercial business.
    • −Part of the strength in casualty in Q2 fiscal 2026 depends on the binding of large construction and data center projects, and management emphasizes that these projects are irregular and that the timing of their closings is difficult to predict, which may increase quarter-to-quarter growth volatility even while the pipeline remains strong.
    • −Despite the Buy consensus, analysts’ targets range from $31 to $69, a wide divergence that reflects valuation sensitivity to the growth and margin trajectory; insider activity was also positive, with net purchases of $4.5 million during the three months through August 13, 2026, but insider transactions remain a weak standalone trading signal, and some sales may have been prearranged.

    Valuation

    The average analyst target is $48.33, with a Buy consensus and a wide range between $31 and $69; the average is below the 52-week range high of $59.185, while the highest target exceeds that high. The breadth of the targets, together with the expected decline in adjusted EBITDAC margin of between 50 and 100 basis points in fiscal 2026 and the anticipated growth slowdown in the second half, makes the stock’s valuation highly dependent on the company’s ability to offset the weak property cycle with growth in reinsurance, casualty, and new products.

    BuyAnalyst target: $48.33(+26.8%)

    Figures in the text are as of 2026-08-30; the live price is shown at the top of the page.

    FAQ

    How does Ryan Specialty generate its revenue?

    The company operates through wholesale brokerage and delegated underwriting authority, including binding authority and underwriting management on behalf of retail brokers and insurance carrier partners. The platform includes more than 300 specialty insurance products and 40 managing general underwriting units, with more than 25 insurance companies, each supporting ten or more of those units. Expansion areas include Ryan Re for reinsurance underwriting management, alternative capital solutions, benefits, self-insurance management, and structured solutions.

    What are the key Q2 fiscal 2026 figures for RYAN stock?

    Revenue according to EDGAR was approximately $916.6 million, and net income was $42.3 million in Q2 fiscal 2026. Management reported year-over-year revenue growth of 7.2%, including organic growth of 6.7%, and adjusted EBITDAC rose 6% to $327 million. The adjusted EBITDAC margin declined 40 basis points to 35.7%, while adjusted earnings per share rose 12.1% to $0.74.

    Why does Ryan Specialty expect growth to slow in the second half of fiscal 2026?

    Organic revenue grew 8.9% in the first half of fiscal 2026, but management maintained its full-year outlook at the high end of the mid-single-digit range. The company expects construction project activity to normalize following large bound accounts in June 2026, along with a difficult year-over-year comparison in Q3. The outlook also incorporates continued declines in property rates, intensifying competition in some casualty markets, and weakness in builders’ risk and binding authority.

    What impact is artificial intelligence having on Ryan Specialty’s operations?

    The company’s FAC Workbench converted a facultative reinsurance submission into a priced, decision-ready file within minutes instead of days, and the company has begun extending this capability to treaty underwriting. During the twelve months ended Q2 fiscal 2026, each RSUM property employee completed 11% more quotes compared with the previous year. The company is also now auditing five times as many files and has begun deploying Agen-tec AI in property inspections to reduce thousands of manual intervention points each month.

    What are the main risks to RYAN’s business in fiscal 2026?

    Property is experiencing intense competition and abundant capacity, with rates on some large and exposed catastrophe accounts declining by between 25% and 35%. Management expects a moderate decline in the property book, with continued pressure on builders’ risk and weaker growth in binding authority. It also expects the adjusted EBITDAC margin to decline by between 50 and 100 basis points during fiscal 2026 because of talent investments, lower fiduciary investment income, and higher healthcare and benefits costs.

    What does Ryan Specialty’s capital policy look like after Q2 fiscal 2026?

    The company repurchased 8.1 million shares for $260 million during Q2 fiscal 2026, then increased the program authorization by $300 million. It added $42 million of purchases during July 2026, while continuing to pay what management described as a modest and sustainable dividend. The company ended the quarter with net credit leverage of 3.3 times, within its stated comfort range of 3 to 4 times, and management does not expect to close a large acquisition during fiscal 2026.